REGN 241213 727.50P (REGN241213P727500) Stock Options, News & Quotes

US OptionsDetailed Quotes

REGN241213P727500

Watchlist

0.08
-5.12-98.46%

15min DelayClose Dec 13 16:00 ET

0.10High0.08Low

Intraday

5D
Daily

News

Weekly Buzz: Tech stocks hit high scores on ominous day
Kevin TraversDec 13 16:29 ET
Market Mixed on Friday the 13th | Livestock
Kevin TraversDec 13 10:46 ET
Thursday Ends in Index Declines | Wall Street Today
Kevin TraversDec 12 16:29 ET
Market Falls Thursday, Producer Inflation Grows, and Tech Pulls Back From Records | LiveStock
Kevin TraversDec 12 11:21 ET
Market Climbs on CPI Inflation and Likelihood of Rate Cuts | Livestock
Kevin TraversDec 11 10:47 ET
BofA Restarts Coverage of 11 Large-cap Biopharmas
Seeking AlphaDec 10 17:01 ET

Comments

10xStockPicks

5 hours ago

This $2.25 Stock Soon To Turn A Profit Is Highly Likely To Be Acquired Above $10

This unique biotech $Esperion Therapeutics (ESPR.US)$ Esperion has the only FDA approved statin alternative drugs NEXLIZET & NEXLETOL for Primary Prevention, Statins are a class of prescription drugs that help lower cholesterol levels. They are the most common treatment for high cholesterol, an estimated 21 Million Americans are Statin intolerant and or maxed out on Statin drugs and need additional lowering. Over 71 ...

10xStockPicks

6 hours ago

Must BUY Esperion Therapeutics Selling FDA Approved Statin Alternative Drugs Will Soon Be Acquired Suspect The Analysts.

NathanRobert

Nov 13 15:03

5 Quality Stocks That Are Undervalued

🔥 We go over 5 stocks that look undervalued, i show you the numbers for yourself, i own 1 of the stocks on the list, but i try to go over stocks you’ve probably never heard of before! LMK ur thoughts :)
$Hershey (HSY.US)$ $Celsius Holdings (CELH.US)$ $Regeneron Pharmaceuticals (REGN.US)$ $Yelp Inc (YELP.US)$ $Innovative Industrial Properties Inc (IIPR.US)$

https://youtu.be/4qd-58cBqi4

From YouTube

10xStockPicks

Oct 24 07:55

Hugely Undervalued $2 Biotech With 21% Held Short $16 Price Target, Takeover Candidate, Soon Profitable

Esperion $Esperion Therapeutics (ESPR.US)$ We reiterate Strong Buy rating. Esperion has the only FDA approved statin alternative drugs NEXLIZET & NEXLETOL for Primary Prevention, an estimated 21 Million Americans are Statin intolerant and or maxed out on Statin drugs and need additional lowering. Over 71 million Americans take statin drugs, we see continued prescription growth & expect over 5...

+20